Cargando…
A randomized controlled trial evaluating the effects of amlodipine on myocardial iron deposition in pediatric patients with thalassemia major
BACKGROUND: Mortality rates increase due to iron deposition in the cardiac muscles of thalassemia major (TM) patients. Iron overload cardiomyopathy could be treated with a combination therapy of an iron chelator and an L-type calcium channel blocker. We designed a randomized controlled study to asse...
Autores principales: | Khaled, Arwa, Salem, Hoda A, Ezzat, Dina A, Seif, Hadeel M, Rabee, Hoda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659783/ https://www.ncbi.nlm.nih.gov/pubmed/31413542 http://dx.doi.org/10.2147/DDDT.S211630 |
Ejemplares similares
-
Effective method of evaluating myocardial iron concentration in pediatric patients with thalassemia major
por: Khaled, Arwa, et al.
Publicado: (2019) -
Myocardial iron overload in thalassemia major. How early to check?
por: Meloni, Antonella, et al.
Publicado: (2014) -
Effect of L-type calcium channel blocker (amlodipine) on myocardial iron deposition in patients with thalassaemia with moderate-to-severe myocardial iron deposition: protocol for a randomised, controlled trial
por: Shakoor, Amarah, et al.
Publicado: (2014) -
Effect of Amlodipine/Nebivolol combination therapy on central BP and PWV compared to Amlodipine/Valsartan combination therapy
por: Sultan, El-Zahraa M., et al.
Publicado: (2022) -
How Early Can Myocardial Iron Overload Occur in Beta Thalassemia Major?
por: Yang, Gaohui, et al.
Publicado: (2014)